Effects of Ranolazine on Cloned Cardiac Kv4.3 Potassium Channels

被引:6
作者
Kim, Hee Jae [1 ]
Ahn, Hye Sook [1 ]
Choi, Jin Sung [2 ]
Choi, Bok Hee [3 ]
Hahn, Sang June [1 ]
机构
[1] Catholic Univ Korea, Dept Physiol, Coll Med, Med Res Ctr, Seoul 137701, South Korea
[2] Catholic Univ Korea, Dept Pharm, Puchon, Gyeonggi Do, South Korea
[3] Chonbuk Natl Univ Med Sch, Dept Pharmacol, Jeonju, Jeonbuk, South Korea
关键词
TRANSIENT OUTWARD CURRENT; LONG-QT SYNDROME; K+ CHANNEL; SODIUM-CHANNELS; HUMAN HEART; VENTRICULAR MYOCYTES; AMINOPYRIDINE BLOCK; ANTIARRHYTHMIC-DRUG; ANTIANGINAL AGENT; ALPHA-SUBUNIT;
D O I
10.1124/jpet.111.184176
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of ranolazine, an antianginal drug, on potassium channel Kv4.3 were examined by using the whole-cell patch-clamp technique. Ranolazine inhibited the peak amplitude of Kv4.3 in a reversible, concentration-dependent manner with an IC(50) of 128.31 mu M. The activation kinetics were not significantly affected by ranolazine at concentrations up to 100 mu M. Applications of 10 and 30 mu M ranolazine had no effect on the fast and slow inactivation of Kv4.3. However, at concentrations of 100 and 300 mu M ranolazine caused a significant decrease in the rate of fast inactivation, and at a concentration of 300 mu M it caused a significant decrease in the rate of slow inactivation, resulting in a crossover of the current traces during depolarization. The Kv4.3 inhibition by ranolazine increased steeply be-tween -20 and +20 mV. In the full activation voltage range, however, no voltage-dependent inhibition was found. Ranolazine shifted the voltage dependence of the steady-state inactivation of Kv4.3 in the hyperpolarizing direction in a concentration-dependent manner. The apparent dissociation constant (K(i)) for ranolazine for interacting with the inactivated state of Kv4.3 was calculated to be 0.32 mu M. Ranolazine produced little use-dependent inhibition at frequencies of 1 and 2 Hz. Ranolazine did not affect the time course of recovery from the inactivation of Kv4.3. The results indicated that ranolazine inhibited Kv4.3 and exhibited a low affinity for Kv4.3 channels in the closed state but a much higher affinity for Kv4.3 channels in the inactivated state.
引用
收藏
页码:952 / 958
页数:7
相关论文
共 47 条
  • [1] Interaction of riluzole with the closed inactivated state of Kv4.3 channels
    Ahn, Hye Sook
    Kim, Sung Eun
    Jang, Hyun-Jong
    Kim, Myung-Jun
    Rhie, Duck-Joo
    Yoon, Shin-Hee
    Jo, Yang-Hyeok
    Kim, Myung-Suk
    Sung, Ki-Wug
    Hahn, Sang June
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (01) : 323 - 331
  • [2] Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties
    Antzelevitch, C
    Belardinelli, L
    Zygmunt, AC
    Burashnikov, A
    Di Diego, JM
    Fish, JM
    Cordeiro, JM
    Thomas, G
    [J]. CIRCULATION, 2004, 110 (08) : 904 - 910
  • [3] Antzelevitch Charles, 2004, Journal of Cardiovascular Pharmacology and Therapeutics, V9, pS65, DOI 10.1177/107424840400900106
  • [4] Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 α subunit
    Barry, DM
    Xu, HD
    Schuessler, RB
    Nerbonne, JM
    [J]. CIRCULATION RESEARCH, 1998, 83 (05) : 560 - 567
  • [5] LIDOCAINE BLOCK OF CARDIAC SODIUM-CHANNELS
    BEAN, BP
    COHEN, CJ
    TSIEN, RW
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 1983, 81 (05) : 613 - 642
  • [6] Structure and function of kv4-family transient potassium channels
    Birnbaum, SG
    Varga, AW
    Yuan, LL
    Anderson, AE
    Sweatt, JD
    Schrader, LA
    [J]. PHYSIOLOGICAL REVIEWS, 2004, 84 (03) : 803 - 833
  • [7] Brendel Joachim, 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P273, DOI 10.2174/1568016033477441
  • [8] MOLECULAR MECHANISMS OF LOCAL-ANESTHESIA - A REVIEW
    BUTTERWORTH, JF
    STRICHARTZ, GR
    [J]. ANESTHESIOLOGY, 1990, 72 (04) : 711 - 734
  • [9] Effects of flecainide and quinidine on Kv4.2 currents:: voltage dependence and role of S6 valines
    Caballero, R
    Pourrier, M
    Schram, G
    Delpón, E
    Tamargo, J
    Nattel, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (08) : 1475 - 1484
  • [10] Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions
    Chaitman, Bernard R.
    [J]. CIRCULATION, 2006, 113 (20) : 2462 - 2472